BioSpace News Archive

GigaGen, a biotechnology company advancing transformative antibody drugs for immune deficiency, infectious diseases, transplant rejection and checkpoint resistant cancers, and a subsidiary of Grifols, announced today that it will present an abstract in a poster session at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting, which is being held on April 10-15 and May 17-21.

Antares Pharma and other growing innovators leverage new class of AI technology to provide customers with a true omnichannel experience

Hospital for Special Surgery has become the first hospital in New York State to receive the nation’s highest honor for nursing excellence five times.

Hijack RNA™ Treatment Strategy Shows Successful Results After Preclinical Trials Using SARS-CoV-2’s Own Key Protein Enzymes to Inactivate and Kill The Virus Within 48 Hours

Management of each of Mindset and InterVivo believe that the psychedelic pharma industry will benefit greatly from a standardized reference data set to identify and develop medicines with enhanced therapeutic benefit and improved safety and pharmacological profiles.

Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced it will host an expert perspectives panel on the evolving treatment landscape for idiopathic pulmonary fibrosis (IPF) and the potential for GB0139 on Tuesday, March 30, 2021 at 2pm Eastern Time.

XtalPi, an artificial intelligence drug discovery and development company, is pleased to announce its investment in the Series B financing of PhoreMost, a UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®' disease targets.

Woebot Health, a pioneer in the development and delivery of fast acting digital therapeutics for mental health, announced that the Journal of Medical Internet Research (JMIR), a peer-reviewed medical journal covering eHealth, has published the results of its latest study.

The American Diabetes Association® and Beyond Type 1 unveil the ADA X BT1 Collab

Nexxt Spine, LLC a leading developer, manufacturer, and distributor of spinal solutions is proud to announce that the company has reached the milestone of over 11,000 NEXXT MATRIXX® 3D printed porous interbody products sold.